AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Enzymatic Compounds are Prognostic for Survival.(of ovarian cancer)

Women's Health Weekly

| February 15, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 FEB 15 - (NewsRx.com) -- Sonia Nichols, staff medical writer -- Important information about the ratio of two enzymes found in epithelial ovarian cancer tissues could potentially be used to develop new anti-cancer therapies.

Although neither of the enzymes alone is an independent predictor of patient outcome, when jointly examined in terms of their ratios, they are significant indicators for survival, researchers at Shimane Medical University report.

Dihydropyrimidine dehydrogenase (DPD) and thymidine phosphorylase (TP) are the two enzymes described in the Journal of Clinical Oncology by R. Fujiwaki et al. Both have a significant relationship to thymine. According to investigators, (DPD) degrades thymine, while TP is the catalyst that changes thymidine into thymine.

For this study, 85 epithelial ovarian cancers were compared with 27 normal ovaries. In each sample, Fujiwaki and associates examined DPD and TP gene expression using standard laboratory methodologies.

"DPD gene expression was significantly lower in epithelial ovarian cancers than in normal ovaries (P[less than]0.0001), whereas TP gene expression and the ratio of TP to DPD gene expression (TP:DPD) were significantly higher in epithelial ovarian cancer (P[less than]0.0001 for both)," noted Fujiwaki et al.

Neither DPD nor the ratio tended to correlate with any one particular finding relative to clinical appearance, according to ...

Related articles from newspapers, magazines, journals, and more
Researchers develop first mouse model.(of epithelial ovarian cancer)
Newspaper article from: Cancer Weekly April 8, 2003 700+ words
...human ovarian cancer - epithelial ovarian cancer. The mouse model provides...her colleagues develop epithelial ovarian cancer in both ovaries. This...transgenic animals that develop epithelial ovarian cancer that spreads to the peritoneal...
Researchers develop first mouse model.(for epithelial ovarian cancer)
Magazine article from: Women's Health Weekly April 10, 2003 700+ words
...human ovarian cancer - epithelial ovarian cancer. The mouse model provides...her colleagues develop epithelial ovarian cancer in both ovaries. This...transgenic animals that develop epithelial ovarian cancer that spreads to the peritoneal...
Characteristics related to ovarian cancer risk: collaborative analysis of seven...
Newspaper article from: Cancer Weekly February 1, 1993 700+ words
...designed to evaluate risk of epithelial ovarian cancer in black women in relation...subjects with diagnosis of epithelial ovarian cancer between 1971 and 1986...characteristics. Decreased risk of epithelial ovarian cancer in black women was associated...
Initial chemotherapy beneficial in epithelial ovarian cancer.(News)
Magazine article from: OB GYN News Lowry, Fran March 1, 2006 700+ words
...patients with advanced epithelial ovarian cancer, a retrospective comparative...Most women with advanced epithelial ovarian cancer receive initial surgery...was 85% in 98 advanced epithelial ovarian cancer patients who received...
Effect of delays in primary care referral on survival of women with epithelial...
Magazine article from: British Medical Journal Kirwan, John MJ Tincello, Douglas G Herod, Jonathan JO Frost, Olive Kingston, Robert E January 19, 2002 700+ words
...care for patients with epithelial ovarian cancer and to identify factors...Subjects 135 patients with epithelial ovarian cancer identified from an audit...records of patients with epithelial ovarian cancer whom we had previously...
Neoadjuvant chemotherapy followed by surgical cytoreduction in advanced...
Magazine article from: Indian Journal of Cancer Deo, Svs Goyal, Hemant Shukla, N. Raina, V. Kumar, Lalit Srinivas, G. July 1, 2006 700+ words
...NACT in advanced ovarian cancer. In this study...patients with advanced epithelial ovarian cancer. Materials and...of a prospective ovarian cancer database of the...patients with advanced epithelial ovarian cancers treated...
Gemcitabine yields favorable results vs. recurrent epithelial ovarian cancer.
Newspaper article from: Cancer Weekly June 29, 2004 700+ words
...patients with recurrent epithelial ovarian cancer and yielded clinical benefit...treatment of recurrent epithelial ovarian cancer." Given the 5-year...for women with advanced epithelial ovarian cancer, Inbar and associates...
Side of origin of epithelial ovarian cancer.
Magazine article from: British Medical Journal Johannes, Catherine B. Kaufman, David W. Rosenberg, Lynn Palmer, Julie R. Stolley, Paul D. Lewis, John L., Jr. Zauber, Ann G. Warshauer, M. Ellen Shapiro, Samuel January 4, 1992 700+ words
...3] Among 214 cases of epithelial ovarian cancer he found that significantly...June 1989. All cases of epithelial ovarian cancer, stage I or greater...that the hypothesis that epithelial ovarian cancer arises more commonly on...
Algorithm predicts epithelial ovarian cancer risk.(WOMEN'S HEALTH)
Magazine article from: Family Practice News MacNeil, Jane Salodof April 1, 2009 700+ words
...at high or low risk for epithelial ovarian cancer based on menopausal stares...classified 94% of women with epithelial ovarian cancer in a prospective, double...disease and all stages of epithelial ovarian cancer determined ROMA's sensitivity...
Hormone replacement therapy formulations and risk of epithelial ovarian cancer.
Newspaper article from: Clinical Oncology Alert November 1, 2002 700+ words
...pattern of altered risk for ovarian cancer and the overall use of HRT...and the risk of invasive epithelial ovarian cancer in women participating in...between any use of HRT and epithelial ovarian cancer. Although use of unopposed...
For more facts and information, see all results

Source: HighBeam Research, Enzymatic Compounds are Prognostic for Survival.(of ovarian cancer)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA